Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | revenue | rating |
---|---|---|---|---|---|---|---|
Acumen Pharmaceuticals, Inc. | $2.37 | $157.41 M | -2.5 | 51 | $0 | ||
Arcellx, Inc. | $54.72 | $2.72 B | -49.3 | 130 | $110.32 M | ||
Akero Therapeutics, Inc. | $21.93 | $1.59 B | -7.1 | 58 | $0 | ||
Day One Biopharmaceuticals, Inc. | $13.50 | $1.12 B | -5.11 | 174 | $0 | ||
Hepion Pharmaceuticals, Inc. | $1.02 | $6.02 M | -0.12 | 22 | $0 | ||
HOOKIPA Pharma Inc. | $0.58 | $79.07 M | -1.71 | 151 | $20.13 M | ||
Intercept Pharmaceuticals, Inc. | $19.00 | $794.69 M | -17.43 | 341 | $285.71 M | ||
Inozyme Pharma, Inc. | $4.49 | $286.39 M | -3.43 | 59 | $0 | ||
Madrigal Pharmaceuticals, Inc. | $271.67 | $5.21 B | -10.55 | 376 | $0 | ||
Mereo BioPharma Group plc | $3.59 | $479.72 M | -22.8 | 33 | $10.00 M | ||
Pliant Therapeutics, Inc. | $10.58 | $672.63 M | -3.9 | 158 | $1.58 M | ||
Reata Pharmaceuticals, Inc. | $172.36 | $6.57 B | -66.29 | 321 | $2.22 M | ||
Stoke Therapeutics, Inc. | $12.67 | $774.50 M | -6.14 | 110 | $8.78 M | ||
Terns Pharmaceuticals, Inc. | $6.86 | $462.44 M | -5.67 | 66 | $0 | ||
TG Therapeutics, Inc. | $18.79 | $2.45 B | 52.83 | 284 | $233.66 M | ||
Viking Therapeutics, Inc. | $50.47 | $6.17 B | -60.86 | 28 | $0 | ||
X4 Pharmaceuticals, Inc. | $0.56 | $169.62 M | -1.51 | 116 | $0 |